The director at the Foundation for the National Institutes of Health discussed relevant biomarkers for Alzheimer disease and their role as novel therapeutics continue to emerge. [WATCH TIME: 5 minutes]
Alessio Travaglia, PhD
Advertisement
Articles by Alessio Travaglia, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
A Step Forward in Multiple System Atrophy: Phase 2 Findings Reinforce ATH434’s Disease-Modifying Potential
2
Understanding Key Clinical and Genetic Biomarkers in Huntington Disease Research: Sarah O'Shea, MD, MSc
3
Ketogenic Diet Shows Significant Effect on Seizure Reduction in Children With Drug-Resistant Epilepsy
4
Real-World Data Highlight Increased Safety Events of Dopamine D2 Receptor Antagonists in Pediatric Tourette Syndrome
5
